MedTrace Logo

Luna Interbody System for Fusion Trial

NCT01551901 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-09-19

No results posted yet for this study

Summary

The purpose of this trial is to evaluate the performance, safety and effectiveness of the Luna system for the treatment of degenerative disc disease.

Conditions

  • Lower Back Pain
  • Degenerative Disc Disease (DDD)

Interventions

DEVICE

Spinal fusion

Spinal fusion procedures in skeletally mature patients with symptomatic degenerative disc disease (DDD) at one or two contiguous levels from L2-S1 with up to grade 1 spondylolisthesis

Sponsors & Collaborators

  • Benvenue Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Alphonse Lubansu, M.D. · H.U.B Erasme

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551901 on ClinicalTrials.gov